12:00 AM
 | 
Feb 07, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Beraprost: Began Phase III trial

United Therapeutics Corp. (UTHR), Silver Spring, Md.
Product: Beraprost
Business: Cardiovascular
Therapeutic category: Vasodilation
Target: Pulmonary blood vessels and...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >